ABBOTT LABORATORIES
Ticker: 1800
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 11.2K-1.8% | 11.4K+2.0% | 11.1K+7.6% | 10.4K-2.6% | 10.6K+2.5% | 10.4K+4.1% | 10.0K-1.8% | 10.1K |
| Total Income | 11.2K-1.8% | 11.4K+2.0% | 11.1K+7.6% | 10.4K-2.6% | 10.6K+2.5% | 10.4K+4.1% | 10.0K-1.8% | 10.1K |
| EXPENSES | ||||||||
| Expenditure | 9.8K+5.4% | 9.3K+2.4% | 9.1K+4.9% | 8.7K-1.3% | 8.8K+0.8% | 8.7K+1.5% | 8.6K+1.0% | 8.5K |
| Tax | 372.00-30.6% | 536.00+44.5% | 371.00-18.1% | 453.00+54.1% | 294.00-3.6% | 305.00+44.5% | 211.00-10.2% | 235.00 |
| PROFIT | ||||||||
| PBT | 1.4K-33.5% | 2.2K+1.4% | 2.1K+20.9% | 1.8K-8.4% | 1.9K+20.7% | 1.6K+11.9% | 1.4K-14.1% | 1.7K |
| Net Profit | 1.1K-34.5% | 1.6K-7.6% | 1.8K+34.3% | 1.3K-19.5% | 1.6K+26.4% | 1.3K+6.3% | 1.2K-14.7% | 1.4K |
| KEY METRICS | ||||||||
| OPM % | 12.05%-6.04pp | 18.09%-0.32pp | 18.42%+2.07pp | 16.34%-1.14pp | 17.48%+1.40pp | 16.08%+2.17pp | 13.91%-2.33pp | 16.24% |
| NPM % | 9.65%-4.81pp | 14.46%-1.51pp | 15.97%+3.18pp | 12.79%-2.69pp | 15.48%+2.93pp | 12.55%+0.25pp | 12.29%-1.86pp | 14.16% |
| EPS | 0.62-34.0% | 0.94-7.8% | 1.02+34.2% | 0.76-19.1% | 0.94+27.0% | 0.74+5.7% | 0.70-14.6% | 0.82 |
Corporate Events
Board MeetingABT
202512Dec
Board Meeting
Nita Ahuja, M.D. named to the Board of Directors, effective …
SEC Filing ↗